AD SCIENTIAM
Ad Scientiam develops innovative digital solutions for patient monitoring in real life. Building on the growing possibilities offered by smartphones, Ad Scientiam creates new clinically-validated medical standards, in a collaborative ecosystem of patients, doctors and researchers. MSCopilot® is Ad Scientiam’s first solution CE marked as a Class 1 medical device, dedicated to the monitoring of patients with multiple sclerosis. Ad Scientiam works on several other solutions in Alzheimer’s Disease, Parkinson's Disease, Rheumatoid Arthritis, etc. Ad Scientiam employs 25 people at its two sites in France (the Pitié-Salpêtrière hospital and Station F campus) and in the United States (Seattle).
AD SCIENTIAM
Industry:
Clinical Trials Health Care Information Technology IT Management Medical
Founded:
2013-09-05
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.adscientiam.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 57 27 41 94
Total Funding:
2.31 M USD
Technology used in webpage:
Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins Global Site Tag Mobile Non Scaleable Content Nginx
Current Employees Featured
Terence Brochu CXO and UX Designer @ Ad Scientiam
CXO and UX Designer
2013-03-01
Liouma Tokitsu Co-Founder and CEO @ Ad Scientiam
Co-Founder and CEO
2013-05-01
Mourad Lafer CTO @ Ad Scientiam
CTO
2016-08-01
Grégoire Lafay Data Scientist @ Ad Scientiam
Data Scientist
Saad Zinai CMO @ Ad Scientiam
CMO
2016-11-01
Founder
Newest Events participated
Participated in VIVA Technology Startup Connect Paris 2016
on 2016-06-30 as exhibitor
Participated in Startup42 Demo Day v0.6
on 2016-02-11 as exhibitor
Official Site Inspections
http://www.adscientiam.com Semrush global rank: 3.93 M Semrush visits lastest month: 3.2 K
- Host name: 40.68.170.100
- IP address: 40.68.170.100
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Ad Scientiam"
Ad Scientiam – Better data for better care
Better datafor better care Découvrir Ad Scientiam Linkedin Twitter Facebook Youtube Nous sommes convaincus qu’une meilleure prise en charge des personnes atteintes de maladies …See details»
Ad Scientiam - Crunchbase Company Profile & Funding
Organization. Ad Scientiam . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact …See details»
Nous connaître – Ad Scientiam
Nous connaître Notre vision Au c?ur du projet d?Ad Scientiam se trouve une conviction : mesurer et suivre l?évolution des maladies graves et invalidantes, en continu et en vie réelle, est …See details»
Ad Scientiam - LinkedIn
Ad Scientiam | 10,154 followers on LinkedIn. Better data for better care | At the heart of Ad Scientiam's project is a conviction: measuring and monitoring the evolution of serious and disabling ...See details»
Ad Scientiam: Contact Details and Business Profile
Adscientiam.fr; View Similar People. Related Companies PREDICTICE. 36 $6.2m QUICKSIGN. 144 $10m La Javaness. 75 $17.5m Planity. 396 $42m Opendatasoft. 103 $11m Invectys. 29 …See details»
Ad Scientiam Company Profile | Management and Employees List
SQL International Organization for Standardization . C# Microsoft . PHP PHP . Frameworks and Libraries (4 Technologies) jQuery Migrate jQuery . ASP.NET Microsoft . jQuery jQuery . ...See details»
Ad Scientiam - Overview, News & Similar companies - ZoomInfo
Sep 17, 2024 Ad Scientiam brings together medical and technological expertise to create new innovating smartphone-based tools for medical and clinical research We offer a mobile and …See details»
Ad Scientiam - VentureRadar
Website: http://www.adscientiam.com. Creating new digital standards for disease monitoring using real-world patient data;Ad Scientiam was created in one of the ...See details»
Ad Scientiam 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Ad Scientiam. Use the PitchBook Platform to explore the full profile.See details»
Ad Scientiam – Better data for better care
Better datafor better care Découvrir Ad Scientiam Linkedin Twitter Facebook Youtube Nous sommes convaincus qu?une meilleure prise en charge des personnes atteintes de maladies graves …See details»
Ad Scientiam - Products, Competitors, Financials, Employees ...
Ad Scientiam to Provide Digital Biomarker Expertise to Abata Therapeutics in First Treg Cell Trial for Progressive MS. Sep 17, 2024. News Provided By Share This Article Ad Scientiam to …See details»
Notre approche – Ad Scientiam
The design of our software solutions follows applicable regulatory and normative requirements, such as ISO 14971 for risk management, IEC 62304 for software development, or ISO 62366 …See details»
Ad Scientiam - Craft
Ad Scientiam allows research and clinical studies to leverage new possibilities offered by the usage of smartphones. The Company's mobile applications integrate proprietary algorithms …See details»
Ad Scientiam | Paris - Facebook
Ad Scientiam, Paris, France. 329 likes · 6 were here. Solution de recueil de données pour la recherche clinique www.adscientiam.fr www.adscientiam.comSee details»
Ad Scientiam Launches Programs to Develop Digital
Feb 28, 2023 szinai@adscientiam.com +33768008666 Matthieu Lamy President mlamy@adscientiam.com +33768008666 . Related Files. FEB2023_Ad Scientiam digital …See details»
Ad Scientiam - VentureRadar
Creating new digital standards for disease monitoring using real-world patient data;Ad Scientiam was created in one of the largest research hospitals... ... Find out ...See details»
Ad Scientiam Launches Programs to Develop Digital Biomarkers …
Feb 28, 2023 szinai@adscientiam.com +33768008666 Matthieu Lamy. President. mlamy@adscientiam.com +33768008666 More Press Releases. Ad Scientiam Launches …See details»
Ad Scientiam announces agreement with Johnson & Johnson …
Nov 5, 2018 Paris, France - Monday, November 5 2018 - Ad Scientiam announced today that it has entered into a collaboration with Janssen Pharmaceutica NV to develop a mobile medical …See details»
Ce que nous faisons – Ad Scientiam
The results generated are shared via a dashboard with the patients' healthcare professionals and provide valuable information to facilitate their clinical decision-making. The patient retains …See details»
Ad Scientiam Launches Programs to Develop Digital Biomarkers …
Feb 28, 2023 Ad Scientiam Logo Ad Scientiam Logo PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, …See details»